Table 1.
Neurodegenerative disorder | ||||
---|---|---|---|---|
Alzheimer’s disease | Parkinson’s disease | Huntington’s disease | Motor neuron disease (amyotrophic lateral sclerosis) | |
Agent | OS | OS | OS | OS |
Glial deregulation | Phagocytic clearance, NI, autophagy, microgliosis, BBB dysregulation | |||
Epigenetic factors | DNA methylation, chromatin remodelling and histone post-translational modifications | |||
Mode of action | Activation of macromolecule, glial cell and tau phosphorylation | Lipid peroxidation and mutation in α-synuclein | Lipid peroxidation | SOD1 activation, inflammation Familial form has SOD1 mutation |
Aberrant protein and cause of neuronal deregulation | Aβ plaques, tau neurofibril tangles | α-Synuclein misfolding protein | Huntingtin (Htt) protein | Multiple impaired protein homeostasis due to ER stress |
Gene association | ApoE4, amyloid precursor protein (APP), presenilin 1/2 (PSEN1/2) | SNCA, LRRK2 | HTT (IT15) | SOD1, TDP-43, FUS |
Area of the brain affected | Hippocampus | Basal ganglia and substantia nigra | Caudate nucleus, putamen and globus pallidus | Lower and upper motor |